Skip to content
Vivid News Community

The Zimbabwean Government Declines ‘Unbalanced’ US Healthcare Assistance Deal Due to Information Apprehensions

Medical funding image
The offered American financial assistance was intended for initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has turned down a major American health deal worth 367 million US dollars (£272m) spanning five years over the United States' insistence on sensitive biological samples.

This move came to light after a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the deal was "lopsided".

An official representative has since explained that the United States was demanding access to health data for research and commercial gain but refused to share the benefits from future vaccines.

"We must now begin the challenging and unfortunate task of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has called for continued dialogue to find a deal acceptable to both sides so the country's critical HIV programme can proceed.

Broader Background

This development comes after a comparable case in Kenya, where a high court blocked a similar deal with the US following legal challenges were filed about the safety of Kenyans' health data.

After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government deals to boost transparency and accountability.

According to reports, 16 nations in Africa have to date signed these new health pacts, representing over $18.3bn in new funding.

Details of the Declined Deal

The funds for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the arrangement was "unfair".

"Our nation was requested to share its biological resources and data indefinitely, with no corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.

"Put simply, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our population if a future disease outbreak emerge."

Sovereignty and International Frameworks

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems previously set up through the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.

"This system is designed to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to create them."

The government's concerns over the US deal "must not be interpreted as anti-American sentiment," he added.

"We are open to further dialogue with our American counterparts on how subsequent collaboration might be designed in a manner that honours the independence and dignity of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but suggested that negotiations need to persist considering much of the nation's HIV programmes were funded by external financing.

"If specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group said.

The situation highlights the complex tensions between accepting crucial international aid and protecting national sovereignty in an ever more interconnected world.

Written by

Arthur Peck

Elena Voss is a seasoned journalist and editor with over a decade of experience in digital media and investigative reporting.

Vivid News Community

Type to search articles.